天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Cato Research Chemicals Inc.

Firmenname:Cato Research Chemicals Inc.
Telefon:020-
E-Mail:2853283383@qq.com
Nationalit?t:China
URL: https://www.catorm.com/
Produkte insgesamt:17980

Produktkatalog

3-Bromo-2,6-difluoroaniline1262198-07-1C6H4BrF2N
Acalabrutinib Impurity 9C22H19N7O
Baricitinib Impurity 83
Baricitinib Impurity 572920037-85-8
Pemafibrate-13C-d3
Baricitinib Impurity 75
(6-Aminopyridin-3-yl)methanol113293-71-3C6H8N2O
(2R,4R)-Teneligliptin TFA
Pemafibrate Impurity 23
Pemafibrate Impurity 37
Pemafibrate Impurity 42
Enarodustat Impurity 7
Enarodustat Impurity 13
Baricitinib Impurity 90
Acalabrutinib Impurity 23
Abemaciclib Impurity 75
Abemaciclib Impurity 80
Abemaciclib Mesylate1231930-82-7C28H36F2N8O3S
Maribavir Impurity 4176161-52-7C12H13Cl2N3O4
Baricitinib Impurity 682101302-47-8C8H12N2O2S
Acalabrutinib Impurity 10C10H12BrN5
Acalabrutinib Impurity 16
Baricitinib Impurity 651187594-29-1
Mavacamten Impurity 3
Mavacamten Impurity 41642288-94-5C15H19N3O2
Baricitinib Impurity 79
Baricitinib Impurity 81
Xanomeline Impurity 13
Teneligliptin impurity 30
Teneligliptin impurity 34
Pemafibrate Impurity 27
Pemafibrate Impurity 34
Enarodustat Impurity 12
Enarodustat Impurity 4
Enarodustat Impurity 21
Baricitinib Impurity 94
Abemaciclib Impurity 74
Abemaciclib Impurity 66
Abemaciclib Impurity 89
Xanomeline oxalate141064-23-5C14H23N3OS.C2H2O4
CyclopropanemethanolCyclopropylmethanol2516-33-8C4H8O
N-Boc-(R)-2-(3-Thiazolidinylcarbonyl)pyrrolidine155251-72-2C13H22N2O3S
Teneligliptin Impurity 61415908-67-6C13H20N2O4S
Teneligliptin D81391012-95-5C22H30N6OS
Baricitinib Impurity N3136823-41-1C9H14O2
Tert-butyl ((3-chloropyrazin-2-yl)methyl)carbamate1823551-51-4C10H14ClN3O2
Teneligliptin Impurity 71404559-22-3C27H38N6O3S
N-Boc-3-Hydroxyazetidine141699-55-0C8H15NO3
Baricitinib Impurity 22964606-44-6C15H15N7O2S
Ethyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate1637223-69-8C17H22N4O2
Acalabrutinib Impurity 2C26H23N7O3
Xanomeline metabolite A174656-57-6C11H15N3O3S
1-(Ethylsulfonyl)azetidin-3-ol1340173-28-5C5H11NO3S
Abemaciclib Impurity 49C11H13BrF2N2
5,6-Dichloro-N-isopropyl-1H-benzo[d]imidazol-2-amine176161-55-0C10H11Cl2N3
Baricitinib Impurity 782055723-11-8C7H15NO5S2
Teneligliptin impurity 31C22H30N6O2S
Acalabrutinib Impurity 13
Baricitinib-D31564242-30-3C16H17N7O2S
Maribavir Impurity 3C16H21Cl2N3O4
Baricitinib Impurity 522910813-43-1C16H18N6O4S
Teneligliptin Impurity 25
Baricitinib Impurity 69BenorilatC17H15NO5
Ethyl 2-cyano-4,4-diethoxybutyrate52133-67-2C11H19NO4
2-Acetamido-5-pyridinecarboxyllic Acid21550-48-1C8H8N2O3
Xanomeline Impurity 11131987-69-4C13H17N3OS
Teneligliptin Impurity 14
Abemaciclib Impurity 682138499-06-4C27H32F2N8O
2-Bromo-5-(bromomethyl)pyridine101990-45-8C6H5Br2N
Clascoterone Impurity 3C25H34O7
Xanomeline Impurity 72414049-88-8
Baricitinib Impurity 97
6-Aminopyridine-3-carboxaldehyde69879-22-7C6H6N2O
Abemaciclib Impurity 46C16H20ClFN6
Pemafibrate Impurity 21
Pemafibrate Impurity 51
Pemafibrate Impurity 41
Pemafibrate Impurity 46
Enarodustat Impurity 11
Enarodustat Impurity 17
Acalabrutinib Impurity 20
Abemaciclib Impurity 56
Abemaciclib Impurity 79
Abemaciclib Impurity 85
3-Chloro-2-(hydroxymethyl)pyrazine89283-32-9C5H5ClN2O
Mavacamten Intermediates Impurity 1887581-47-7C7H9ClN2O2
Thiazolidine hydrochloride14446-47-0C3H8ClNS
Abemaciclib Impurity 47C13H14BrFN2
N-(Pyridin-2-yl)benzamide4589-12-2C12H10N2O
Abemaciclib Impurity 61827587-92-8C10H14N4O
Acalabrutinib Impurity 21C18H17ClN4O2
Mavacamten1642288-47-8C15H19N3O2
N-(1,4-dimethylpentyl)-N'-phenylbenzene-1,4-diamineN-(1,4-Dimethylpentyl)-N'-phenylbenzol-1,4-diamin3081-01-4C19H26N2
Ufenamate67330-25-0C18H18F3NO2
2,5-Dimethylaniline2,5-Xylidin95-78-3C8H11N
HydroxyprocaineHydroxyprocain487-53-6C13H20N2O3
Betaine salicylate17671-53-3C12H17NO5
1,3-Dinitrobenzene1,3-Dinitrobenzol99-65-0C6H4N2O4
Solvent Red 1973-(Diethylamino)-7-imino-7H-[1]benzopyrano[3',2':3,4]pyrido[1,2-a]benzimidazol-6-carbonitril52372-39-1C23H19N5O
Fluorescent Brightener 35355585-28-9
Copyright 2019 ? ChemicalBook. All rights reserved